IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Q3 2023 Holdings

Filed 2023-11-14 | 29 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$162.0M1,831,03515.3%
Insmed Inc(INSM)COM457669307$148.7M5,889,49114.1%
United Therapeutics Corp(UTHR)COM91307C102$130.1M575,90712.3%
Amicus Therapeutics Inc(FOLD)COM03152W109$128.0M10,524,02212.1%
Biogen Inc(BIIB)COM09062X103$98.0M381,2829.3%
Prothena Corp PLC(PRTA)COMG72800108$80.0M1,657,4587.6%
Revance Therapeutics Inc(RVNCEUR)COM761330109$60.0M5,228,6095.7%
Staar Surgical Co(STAA)COM852312305$55.2M1,374,8225.2%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$50.1M2,405,7934.7%
Sage Therapeutics Inc(SG7)COM78667J108$20.7M1,005,7762.0%
Ehealth Inc(EHTH)COM28238P109$20.3M2,739,3791.9%
Align Technology Inc(ALGN)COM016255101$17.0M55,7051.6%
Alkermes PLC(ALKS)COMG01767105$16.9M603,4001.6%
Sarepta Therapeutics Inc(SRPT)COM803607100$11.4M94,0301.1%
Novocure LTD(NVCR)COMG6674U108$10.7M660,2751.0%
Anaptysbio Inc(ANAB)COM032724106$7.7M431,2240.7%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$7.6M5,675,8760.7%
Nevro Corp(NVROEUR)COM64157F103$7.4M386,8320.7%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$6.9M472,6000.6%
Gossamer BIO Inc(GOSS)COM38341P102$5.4M6,530,2880.5%
Cytokinetics Inc(CYTK)COM23282W605$3.3M111,7170.3%
Relmada Therapeutics Inc(RLMD)COM75955J402$2.2M732,4000.2%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$2.0M64,7000.2%
Travere Therapeutics Inc(TVTX)COM89422G107$1.5M166,0690.1%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$1.2M278,9850.1%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.1M160,8000.1%
Kezar Life Sciences IncCOM49372L100$780.9K656,2000.1%
Tactile Systems Technology I(TCMD)COM87357P100$380.8K27,1000.0%
Urogen Pharma LTD(URGN)COMM96088105$343.2K24,5000.0%